Lancashire (LRE) Competitors

Mediclinic International (LON:MDC) and Lancashire (LON:LRE) are both construction companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Does the media prefer MDC or LRE?

In the previous week, Lancashire's average media sentiment score of 0.75 beat Mediclinic International's score of 0.00 indicating that Lancashire is being referred to more favorably in the news media.

Company	Overall Sentiment
Mediclinic International	Neutral
Lancashire	Positive

Do insiders & institutionals have more ownership in MDC or LRE?

39.2% of Mediclinic International shares are owned by institutional investors. Comparatively, 60.5% of Lancashire shares are owned by institutional investors. 48.9% of Mediclinic International shares are owned by company insiders. Comparatively, 0.6% of Lancashire shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has better valuation & earnings, MDC or LRE?

Lancashire has lower revenue, but higher earnings than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mediclinic International	£3.38B	0.00	£169M	£0.23	N/A
Lancashire	£536.12M	3.50	£199.02M	£52.49	11.85

Which has more volatility & risk, MDC or LRE?

Mediclinic International has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, Lancashire has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.

Is MDC or LRE a better dividend stock?

Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays an annual dividend of GBX 18 per share and has a dividend yield of 2.9%. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire pays out 34.3% of its earnings in the form of a dividend. Lancashire is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do analysts rate MDC or LRE?

Lancashire has a consensus price target of GBX 663, indicating a potential upside of 6.59%. Given Lancashire's stronger consensus rating and higher possible upside, analysts clearly believe Lancashire is more favorable than Mediclinic International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mediclinic International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lancashire	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is MDC or LRE more profitable?

Lancashire has a net margin of 37.12% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 10.76% beat Mediclinic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mediclinic International	4.99%	5.50%	2.30%
Lancashire	37.12%	10.76%	6.75%

Summary

Lancashire beats Mediclinic International on 13 of the 16 factors compared between the two stocks.